Feedback PLC Bleepa wins two NHS Contract Awards (0271I)
April 12 2022 - 2:00AM
UK Regulatory
TIDMFDBK
RNS Number : 0271I
Feedback PLC
12 April 2022
Feedback plc
Bleepa wins two NHS Contract Awards
-- Award of twelve-month contracts with two NHS Trusts, for an aggregate value of GBP200,000
London, 12 April 2022 : Feedback plc (AIM: FDBK, " Feedback" or
the "Company"), the specialist clinical communication company,
announces that it has been awarded two twelve-month contracts to
provide its flagship product, Bleepa(R) , across two NHS Trusts,
for an aggregate value of GBP200,000.
The first contract follows a successful pilot and co-development
on the platform over the last two years, representing the Company's
first full-cycle realisation of its pilot-to-contract business
model.
The second represents a contract renewal following the success
of an initial one-year contract, at a higher value than the initial
contract.
Tom Oakley, CEO of Feedback, said:
"We are delighted to see the value of Bleepa as a core clinical
system recognised through the award of two customer contracts. Over
the last year we have significantly grown the number of Bleepa
users and it is good to see this growth recognised in the uplift in
contract value achieved. These contracts are early evidence of the
success of our 2019 strategic shift."
Further information on Feedback and its products can be found on
the Company's website:
https://fbkmed.com/feedback-plc/reports-and-presentations/
-Ends-
Enquiries:
Feedback plc +44 (0) 20 3997 7634
Tom Oakley, CEO IR@fbk.com
Anesh Patel, CFO
Panmure Gordon (UK) Limited (NOMAD
and Broker)
Emma Earl/Freddy Crossley (Corporate
Finance)
Rupert Dearden (Corporate Broking) +44 (0)20 7886 2500
Walbrook PR Ltd Tel: 020 7933 8780 or feedbackplc@walbrookpr.com
Paul McManus/Nick Rome/Nicholas 07980 541 893 or 07748 325 236
Johnson or 07884 664 686
About Feedback
Feedback plc is a specialist clinical communications business,
with a mission to improve the efficiency and quality of
communications for frontline clinicians and hospitals with a key
focus on building solutions that enhance access to high quality
patient data.
Feedback has developed a toolkit of clinical communications
apps. Its core, regulatory approved product is Bleepa, a
revolutionary medical imaging app enabling remote and secure
communications between frontline clinicians and teams. CareLocker
is an evolutionary GDPR compliant patient-centric cloud
architecture - its proprietary technology enables an easy route to
creation and mobilisation of individual healthcare records. Bleepa
Box is a specialist tool to enable image transfer from remote
settings to the Bleepa platform over mobile networks.
The Company has a number of growth opportunities domestically
and internationally across a range of markets including the NHS,
the veterinary market and private healthcare providers and its
highly scalable Software as a Service ("SaaS")-based revenue model
is expected to provide increasing levels of visibility as the
Company grows its customer base.
About RNS Reach announcements
This is an RNS Reach announcement. RNS Reach is an investor
communication service aimed at assisting listed and unlisted
(including AIM quoted) companies to distribute media only /
non-regulatory news releases into the public domain. Information
required to be notified under the AIM Rules for Companies, Market
Abuse Regulation or other regulation would be disseminated as an
RNS regulatory announcement and not on RNS Reach.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCKZGMDVMNGZZM
(END) Dow Jones Newswires
April 12, 2022 02:00 ET (06:00 GMT)
Feedback (LSE:FDBK)
Historical Stock Chart
From Jul 2024 to Jul 2024
Feedback (LSE:FDBK)
Historical Stock Chart
From Jul 2023 to Jul 2024